Enhanced hepatocyte-selective in vivo gene expression by stabilized galactosylated liposome/plasmid DNA complex using sodium chloride for complex formation

被引:62
作者
Fumoto, S [1 ]
Kawakami, S [1 ]
Ito, Y [1 ]
Shigeta, K [1 ]
Yamashita, F [1 ]
Hashida, M [1 ]
机构
[1] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Drug Delivery Res, Sakyo Ku, Kyoto 6068501, Japan
关键词
gene therapy; cationic liposornes; targeting; plasmid DNA; hepatocytes;
D O I
10.1016/j.ymthe.2004.07.015
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
In this study, we demonstrated that the presence of an essential amount of sodium chloride (NaCl) during the formation of cationic liposome/plasmid DNA complexes (lipoplexes) stabilizes the lipoplexes according to the surface charge regulation (SCR) theory. Fluorescence resonance energy transfer analysis revealed that cationic liposomes in an SCR lipoplex (5 and 10 mM NaCl solution in lipoplex) increased fusion. Also, aggregation of SCR lipoplexes was significantly delayed after exposure to saline (150 mM NaCl) as a model of physiological conditions. After intraportal administration, the hepatic transfection activity of galactosylated SCR lipoplexes (5 and 10 mM NaCl solution in lipoplex) was approximately 10- to 20-fold higher than that of galactosylated conventional lipoplexes in mice. The transfection activity in hepatocytes of galactosylated SCR lipoplexes was significantly higher than that of conventional lipoplexes, and preexposure to competitive asialoglycoprotein-receptor blocker significantly reduced the hepatic gene expression, suggesting that hepatocytes are responsible for high hepatic transgene expression of the galactosylated SCR lipoplexes. Pharmacokinetic studies both in situ and in vivo demonstrated a higher tissue binding affinity and a greater expanse of intrahepatic distribution by galactosylated SCR lipoplexes. Moreover, enhanced transfection activity of galactosylated SCR lipoplexes was observed in HepG2 cells, and investigation of confocal microscopic images showed that the release of plasmid DNA in the cell was markedly accelerated. These characteristics partly explain the mechanism of enhanced in vivo transfection efficacy by galactosylated SCR lipoplexes. Hence, information in this study will be valuable for the future use, design, and development of ligand-modified lipoplexes for in vivo applications.
引用
收藏
页码:719 / 729
页数:11
相关论文
共 37 条
[1]   Increased receptor-mediated gene delivery to the liver by protamine-enhanced-asialofetuin-lipoplexes [J].
Arangoa, MA ;
Düzgünes, N ;
de Ilarduya, CT .
GENE THERAPY, 2003, 10 (01) :5-14
[2]   Analysis of hepatic disposition of galactosylated cationic liposome/plasmid DNA complexes in perfused rat liver [J].
Fumoto, S ;
Nakadori, F ;
Kawakami, S ;
Nishikawa, M ;
Yamashita, F ;
Hashida, M .
PHARMACEUTICAL RESEARCH, 2003, 20 (09) :1452-1459
[3]  
Fumoto Shintaro, 2003, Drug Metab Pharmacokinet, V18, P230, DOI 10.2133/dmpk.18.230
[4]   MODE OF FORMATION AND STRUCTURAL FEATURES OF DNA CATIONIC LIPOSOME COMPLEXES USED FOR TRANSFECTION [J].
GERSHON, H ;
GHIRLANDO, R ;
GUTTMAN, SB ;
MINSKY, A .
BIOCHEMISTRY, 1993, 32 (28) :7143-7151
[5]   Evaluation by fluorescence resonance energy transfer of the stability of nonviral gene delivery vectors under physiological conditions [J].
Itaka, K ;
Harada, A ;
Nakamura, K ;
Kawaguchi, H ;
Kataoka, K .
BIOMACROMOLECULES, 2002, 3 (04) :841-845
[6]  
Kawakami S, 2002, CRIT REV THER DRUG, V19, P171
[7]   In vivo gene delivery to the liver using novel galactosylated cationic liposomes [J].
Kawakami, S ;
Fumoto, S ;
Nishikawa, M ;
Yamashita, F ;
Hashida, M .
PHARMACEUTICAL RESEARCH, 2000, 17 (03) :306-313
[8]   Liver- and lobe-selective gene transfection following the instillation of plasmid DNA to the liver surface in mice [J].
Kawakami, S ;
Hirayama, R ;
Shoji, K ;
Kawanami, R ;
Nishida, K ;
Nakashima, M ;
Sasaki, H ;
Sakaeda, T ;
Nakmura, J .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 294 (01) :46-50
[9]   Mannose receptor-mediated gene transfer into macrophages using novel mannosylated cationic liposomes [J].
Kawakami, S ;
Sato, A ;
Nishikawa, M ;
Yamashita, F ;
Hashida, M .
GENE THERAPY, 2000, 7 (04) :292-299
[10]   Asialoglycoprotein receptor-mediated gene transfer using novel galactosylated cationic liposomes [J].
Kawakami, S ;
Yamashita, F ;
Nishikawa, M ;
Takakura, Y ;
Hashida, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 252 (01) :78-83